Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population

NCT07211204 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2026-03-03

No results posted yet for this study

Summary

This study compares the efficacy of cytology (Pap smear) with the molecular screening in their ability to detect reactive cellular changes in the cervix among an open population

Conditions

  • Atypical Squamous Cell of Undetermined Significance
  • ASC-US
  • Atypical Glandular Cells of Uncertain Significance
  • AGUS
  • Cervical Intraepithelial Neoplasia (CIN)
  • CIN 1
  • CIN 2
  • CIN 3
  • Cervical Cancer

Interventions

PROCEDURE

Physical examination

Physical examination and interview for obtaining a medical record

OTHER

Liquid-based cytology

Screening test for cervical precursor lesions and/or cancer. LBC is a procedure in which a cervical smear is examined under the microscope.

OTHER

Molecular screening

The molecular screening detects three human biomarkers associated with cervical precursor lesions and/or cervical cancer. Biomarker detection is done by Western blot and ELISA in human sera.

OTHER

HPV DNA test

HPV DNA detection is performed using a cervical swab.

DIAGNOSTIC_TEST

Colposcopy

A diagnostic procedure to visually examine the cervix, vagina, and vulva with a colposcope.

DIAGNOSTIC_TEST

Histopathology

Is the definitive diagnosis of cervical precursor lesions and cervical cancer. It is the microscopic study of diseased cells and tissues stained with hematoxylin and eosin.

Sponsors & Collaborators

  • Timser SAPI de CV

    lead INDUSTRY

Principal Investigators

  • Leopoldo E Gatica-Galina, MD in OB/GY & Gynecol Oncol · Clinica Reina Madre Metepec

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-02-27
Primary Completion
2026-02-27
Completion
2026-02-27

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07211204 on ClinicalTrials.gov